Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?
NCT00186264 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2019-10-04
Summary
The primary purpose of this study is to examine whether IV hydrocortisone can speed up the time required for Venlafaxine XR to work.
Conditions
- Depressive Disorder, Major
Interventions
- DRUG
-
venlafaxine XR
- DRUG
-
hydrocortisone
Sponsors & Collaborators
-
Wyeth is now a wholly owned subsidiary of Pfizer
collaborator INDUSTRY - lead OTHER
Principal Investigators
-
Charles DeBattista · Stanford University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-08-31
- Primary Completion
- 2006-04-30
- Completion
- 2006-04-30
Countries
- United States
Study Locations
More Related Trials
-
Study Evaluating Venlafaxine Extended-Release in Depressed and Anxious Patients
NCT00546923 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder
NCT00122850 ·Status: COMPLETED ·Phase: PHASE3
-
Improving Retention of Hispanics Receiving Antidepressant Therapy
NCT00057642 ·Status: COMPLETED ·Phase: NA
-
Brain Imaging Techniques That Predict Antidepressant Responsiveness
NCT00909155 ·Status: COMPLETED ·Phase: NA
-
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
NCT02951988 ·Status: COMPLETED ·Phase: PHASE3
-
Venlafaxine for Depression in Alzheimer's Disease (DIADs-3)
NCT01609348 ·Status: COMPLETED ·Phase: NA
-
Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder
NCT00087737 ·Status: COMPLETED ·Phase: PHASE3
-
Duloxetine vs. Active Comparator for the Treatment of Depression
NCT00067912 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression
NCT00644982 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
NCT02932943 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive Disorder
NCT00092911 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Venlafaxine XR in Elderly Patients With Major Depression
NCT00177528 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy
NCT01942785 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder
NCT02067793 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating DVS-233 in Adult Outpatients With Major Depressive Disorder
NCT00063206 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Potential Effects of SSR149415 on the Hypothalamic-pituitary-adrenal Axis in Outpatients With Major Depressive Disorder
NCT01606384 ·Status: COMPLETED ·Phase: PHASE2
-
Treatments for Depression: Drug Versus Psychotherapy
NCT00043550 ·Status: COMPLETED ·Phase: PHASE3
-
Randomised Placebo-controlled Venlafaxine-referenced Study of Efficacy and Safety of 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Adults
NCT00839423 ·Status: COMPLETED ·Phase: PHASE2
-
Pentoxifylline for Treatment of Resistant Major Depression
NCT05324735 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder
NCT00122837 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of JNJ26489112 in Patients With Treatment-Resistant Major Depressive Disorder
NCT01114698 ·Status: TERMINATED ·Phase: PHASE2
-
Pilot Study of Betahistine Dihydrochloride in the Treatment of Major Depression With Atypical Features
NCT00585585 ·Status: TERMINATED ·Phase: PHASE2
-
Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks
NCT01557712 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine
NCT06280235 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Efficacy and Safety of Initial Administration of 17 mg Vortioxetine Intravenously With 10 mg/Day Vortioxetine Orally in Patients With Major Depressive Disorder
NCT02919501 ·Status: COMPLETED ·Phase: PHASE2